BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 26671411)

  • 1. A basal-like breast cancer-specific role for SRF-IL6 in YAP-induced cancer stemness.
    Kim T; Yang SJ; Hwang D; Song J; Kim M; Kyum Kim S; Kang K; Ahn J; Lee D; Kim MY; Kim S; Seung Koo J; Seok Koh S; Kim SY; Lim DS
    Nat Commun; 2015 Dec; 6():10186. PubMed ID: 26671411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SRF-YAP-IL6 axis promotes breast cancer stemness.
    Kim T; Lim DS
    Cell Cycle; 2016 May; 15(10):1311-2. PubMed ID: 27184334
    [No Abstract]   [Full Text] [Related]  

  • 3. OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ.
    Zhang Z; Du J; Wang S; Shao L; Jin K; Li F; Wei B; Ding W; Fu P; van Dam H; Wang A; Jin J; Ding C; Yang B; Zheng M; Feng XH; Guan KL; Zhang L
    Mol Cell; 2019 Jan; 73(1):7-21.e7. PubMed ID: 30472188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ΔNp63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signalling.
    Chakrabarti R; Wei Y; Hwang J; Hang X; Andres Blanco M; Choudhury A; Tiede B; Romano RA; DeCoste C; Mercatali L; Ibrahim T; Amadori D; Kannan N; Eaves CJ; Sinha S; Kang Y
    Nat Cell Biol; 2014 Oct; 16(10):1004-15, 1-13. PubMed ID: 25241036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.
    Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A
    Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling.
    Zheng L; Xiang C; Li X; Guo Q; Gao L; Ni H; Xia Y; Xi T
    J Hematol Oncol; 2018 May; 11(1):72. PubMed ID: 29848346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.
    Noto A; De Vitis C; Pisanu ME; Roscilli G; Ricci G; Catizone A; Sorrentino G; Chianese G; Taglialatela-Scafati O; Trisciuoglio D; Del Bufalo D; Di Martile M; Di Napoli A; Ruco L; Costantini S; Jakopin Z; Budillon A; Melino G; Del Sal G; Ciliberto G; Mancini R
    Oncogene; 2017 Aug; 36(32):4573-4584. PubMed ID: 28368399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A MYC-Driven Change in Mitochondrial Dynamics Limits YAP/TAZ Function in Mammary Epithelial Cells and Breast Cancer.
    von Eyss B; Jaenicke LA; Kortlever RM; Royla N; Wiese KE; Letschert S; McDuffus LA; Sauer M; Rosenwald A; Evan GI; Kempa S; Eilers M
    Cancer Cell; 2015 Dec; 28(6):743-757. PubMed ID: 26678338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SRGN crosstalks with YAP to maintain chemoresistance and stemness in breast cancer cells by modulating HDAC2 expression.
    Zhang Z; Qiu N; Yin J; Zhang J; Liu H; Guo W; Liu M; Liu T; Chen D; Luo K; Li H; He Z; Liu J; Zheng G
    Theranostics; 2020; 10(10):4290-4307. PubMed ID: 32292495
    [No Abstract]   [Full Text] [Related]  

  • 10. ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types.
    Lehmann W; Mossmann D; Kleemann J; Mock K; Meisinger C; Brummer T; Herr R; Brabletz S; Stemmler MP; Brabletz T
    Nat Commun; 2016 Feb; 7():10498. PubMed ID: 26876920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell-like Behaviors Contributing to Disease Progression.
    Hayashi H; Higashi T; Yokoyama N; Kaida T; Sakamoto K; Fukushima Y; Ishimoto T; Kuroki H; Nitta H; Hashimoto D; Chikamoto A; Oki E; Beppu T; Baba H
    Cancer Res; 2015 Nov; 75(22):4985-97. PubMed ID: 26420216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related dysfunction in mechanotransduction impairs differentiation of human mammary epithelial progenitors.
    Pelissier FA; Garbe JC; Ananthanarayanan B; Miyano M; Lin C; Jokela T; Kumar S; Stampfer MR; Lorens JB; LaBarge MA
    Cell Rep; 2014 Jun; 7(6):1926-39. PubMed ID: 24910432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin inhibits glioma cells stemness and epithelial-mesenchymal transition via regulating YAP activity.
    Yuan X; Wei W; Bao Q; Chen H; Jin P; Jiang W
    Biomed Pharmacother; 2018 Jun; 102():263-270. PubMed ID: 29567539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP/TAZ.
    Escoll M; Gargini R; Cuadrado A; Anton IM; Wandosell F
    Oncogene; 2017 Jun; 36(25):3515-3527. PubMed ID: 28166194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yap-dependent reprogramming of Lgr5(+) stem cells drives intestinal regeneration and cancer.
    Gregorieff A; Liu Y; Inanlou MR; Khomchuk Y; Wrana JL
    Nature; 2015 Oct; 526(7575):715-8. PubMed ID: 26503053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGFβ induces the formation of tumour-initiating cells in claudinlow breast cancer.
    Bruna A; Greenwood W; Le Quesne J; Teschendorff A; Miranda-Saavedra D; Rueda OM; Sandoval JL; Vidakovic AT; Saadi A; Pharoah P; Stingl J; Caldas C
    Nat Commun; 2012; 3():1055. PubMed ID: 22968701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YAP/TEAD co-activator regulated pluripotency and chemoresistance in ovarian cancer initiated cells.
    Xia Y; Zhang YL; Yu C; Chang T; Fan HY
    PLoS One; 2014; 9(11):e109575. PubMed ID: 25369529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YAP and β-Catenin Cooperate to Drive Oncogenesis in Basal Breast Cancer.
    Quinn HM; Vogel R; Popp O; Mertins P; Lan L; Messerschmidt C; Landshammer A; Lisek K; Château-Joubert S; Marangoni E; Koren E; Fuchs Y; Birchmeier W
    Cancer Res; 2021 Apr; 81(8):2116-2127. PubMed ID: 33574090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of HuR represses osteosarcoma cells migration, invasion and stemness through inhibition of YAP activation and increases susceptibility to chemotherapeutic agents.
    Xu W; Chen C; Xu R; Li Y; Hu R; Li Z; Zhu X
    Biomed Pharmacother; 2018 Jun; 102():587-593. PubMed ID: 29597092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lncRNA B4GALT1-AS1 promotes colon cancer cell stemness and migration by recruiting YAP to the nucleus and enhancing YAP transcriptional activity.
    Zhang Y; Fang Z; Guo X; Dong H; Zhou K; Huang Z; Xiao Z
    J Cell Physiol; 2019 Aug; 234(10):18524-18534. PubMed ID: 30912138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.